Skip to main content

This job has expired

You will need to login before you can apply for a job.

Director, Medical Affairs- Hematology

Employer
CSL Behring
Location
King of Prussia, Pennsylvania
Start date
Jul 10, 2021

View more

Discipline
Clinical, Medical Affairs
Required Education
Doctorate/PHD/MD
Position Type
Full time
Hotbed
Pharm Country

Job Details

With operations in 35+ nations and ~27,000 employees worldwide, CSL is driven to develop and deliver a broad range of lifesaving therapies to treat disorders such as hemophilia and primary immune deficiencies, and vaccines to prevent influenza. Our therapies are also used in cardiac surgery, organ transplantation and burn treatment.

CSL is the parent company of CSL Behring and Seqirus. CSL Behring is a global leader in the protein biotherapeutics industry, focused on bringing to market biotherapies used to treat serious and often rare conditions. CSL Behring operates CSL Plasma, one of the world's largest collectors of human plasma, which is used to create CSL’s therapies. Seqirus is one of the largest influenza vaccine companies in the world and is a transcontinental partner in pandemic preparedness and a major contributor to the prevention and control of influenza globally.

We invite you to take a look at the many career possibilities available around the globe and consider building your promising future at CSL by becoming a member of our team!

Job Description

The Director of Medical Affairs for Congenital Bleeding Disorders (including Hemophilia A, Hemophilia B, Gene Therapy and von Willebrand Disease) within the Hematology Therapeutic Area (TA) is responsible for the development and implementation of global medical strategies that support worldwide commercialization for assigned products within Congenital Bleeding Disorders of the TA.  Based on a comprehensive understanding of the science and medical need for Congenital Bleeding Disorders marketed products and pipeline assets, the incumbent will take a leadership role in the definition of medical strategies for in-line products, life cycle management, new products and assessment of strategic business development opportunities.

Responsibilities:

  • Represent GCD Medical Affairs on project delivery teams and work closely with R&D to ensure the unmet need of the patient is well defined and understood and that the trial designs are aligned with this.
  • Work closely with global Marketing, Market Access and Medical Education colleagues to develop and implement fully integrated Go-to-Market and Brand Medical Affairs strategies and tactical activities.
  • Work closely with regions and countries to ensure pull through of global tactics and sharing of best practices for assigned products, both in-line and pipeline, across the TA.
  • Lead scientific interactions with the medical community, coordinate the company publication activities and provide medical support within the TA and to the regional and country based teams.
  • Develop and maintain relationships with KOLs and patient advocacy groups and partner closely with internal Global Policy and Global Advocacy colleagues in these areas.

Qualifications:

Education:

PharmD/PhD or MD (preferred).

Experience:
• Medical degree with relevant scientific/medical background
• 10+ years' pharmaceutical/ biotherapeutics industry experience including experience in therapeutic/specialist area and/or M.D. with at least 5 years of relevant industry experience and/or M.D. with at least 10 years of academic experience relevant to the Hematology TA. Proven medical and scientific expertise in Hematology required.   Experience and expertise in Gene Therapy is a plus.
• Sound experience interacting with commercial functions within the healthcare industry
• Knowledge of therapeutic specialty area

Travel:

Willingness and flexibility to meet overseas travel requirements (up to 20%).

#LI-JG1

Company

As the third largest global biotechnology company with employees in more than 35 countries, CSL Behring is focused on serving patients with serious and rare diseases, including coagulation disorders, primary immune deficiencies, hereditary angioedema, respiratory disease and neurological disorders. We collaborate with patient and biomedical communities to improve access to therapies, advance scientific knowledge and support future medical research. 


CSL Behring's dynamic environment fosters innovation and attracts the best and brightest who share a commitment to helping save lives. People here are free to live their Promising FUTURES where they can fulfill their individual career aspirations and realize their potential. 


CSL Behring is committed to diversity and inclusion, both of which underpin our Values of patient focus, innovation, collaboration, integrity and superior performance. We believe that by harnessing and honoring the unique capabilities, experiences and perspectives of our people, we are better able to serve our patients.


CSL Behring operates one of the world's largest plasma collection networks, CSL Plasma. The parent company, CSL Limited, headquartered in Melbourne, Australia, employs more than 27,000 people, and provides its life-saving medicines in more than 70 countries. 
For more information visit www.cslbehring.com. Help us deliver on our promise to save lives and protect the health of people around the world. Promising FUTURES start at CSL Behring!

Stock Symbol: CSL

Stock Exchange: Australian Securities Exchange

Company info
Phone
610-878-4000
Location
1020 First Avenue
King of Prussia
Pennsylvania
19406
United States

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert